Loading…
May Measurement Month 2020: An Analysis of Blood Pressure Screening Results From China
We reported the blood pressure data obtained in the May Measurement Month (MMM) China project in 2020 during the COVID-19 control period. The study participants were adults (≥ 18 years), ideally in whom blood pressure had not been measured in the previous year. Blood pressure was measured three time...
Saved in:
Published in: | The journal of clinical hypertension (Greenwich, Conn.) Conn.), 2025-01, Vol.27 (1), p.1-4 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c231t-8263d50d896d171a541e1da17baf42dde47e8dc3c6fe264f2122edf3eb7369913 |
container_end_page | 4 |
container_issue | 1 |
container_start_page | 1 |
container_title | The journal of clinical hypertension (Greenwich, Conn.) |
container_volume | 27 |
creator | Chen, Xin Zhang, Li-Ping Wang, Xiao-Long Zhang, Ning-Ru Yu, Jing Xu, Li-Ying Li, Tong-She Luan, Hong Zhang, Juan Hu, Ya-Min Liu, Dan Zheng, Qi-Dong Li, Yan Wang, Ji-Guang |
description | We reported the blood pressure data obtained in the May Measurement Month (MMM) China project in 2020 during the COVID-19 control period. The study participants were adults (≥ 18 years), ideally in whom blood pressure had not been measured in the previous year. Blood pressure was measured three times consecutively with a 1-min interval in the sitting position, using a validated automated BP monitor (Omron HEM-7081IT), and transmitted to a central database via a smartphone app. The measurement was performed at 136 sites across 29 China provinces. The 100 728 participants had a mean (±SD) age of 45.6 (±18.3) years and included 56 097 (55.7%) women. The mean systolic/diastolic blood pressure was 120.0/76.9 mm Hg. The proportion of hypertension was 28.9% (n = 29 135), and the awareness, treatment, and control rates of hypertension were 45.3% (n = 13 212), 39.7% (n = 1573), and 24.4% (n = 7101), respectively. After adjustment for age, gender, and use of antihypertensive medication, systolic/diastolic BP were significantly higher with cigarette smoking (n = 8070, +0.5/+1.0 mm Hg, p < 0.05), mild (n = 4369, +1.2/+1.3 mm Hg, p |
doi_str_mv | 10.1111/jch.14919 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3119723428</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3119723428</sourcerecordid><originalsourceid>FETCH-LOGICAL-c231t-8263d50d896d171a541e1da17baf42dde47e8dc3c6fe264f2122edf3eb7369913</originalsourceid><addsrcrecordid>eNpVkdtKxDAQhoMoni98AcmlXlQ7Sdo03si6eAIXxdNtyDbTbaVt1qQV9u3telg0DCTMfPyZmZ-QA4hPYDinb3l5AkKBWiPbIBOIJMh0fXgnTETpkNkiOyG8xXHCuYo3yRZXgkupkm3yOjELOkETeo8Nth2duLYrKYtZfEZH7RCmXoQqUFfQi9o5Sx88hiVNn3KP2FbtjD5i6Osu0CvvGjouq9bskY3C1AH3f-5d8nJ1-Ty-ie7ur2_Ho7soZxy6KGMpt0lsM5VakGASAQjWgJyaQjBrUUjMbM7ztECWioIBY2gLjlPJU6WA75Lzb915P23Q5sME3tR67qvG-IV2ptL_K21V6pn70ACSKSmWCkc_Ct699xg63VQhx7o2Lbo-aA6gJOOCZQN6_I3m3oXgsVj9A7FeGqEHI_SXEQN7-LexFfm7ef4Je1SDgA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3119723428</pqid></control><display><type>article</type><title>May Measurement Month 2020: An Analysis of Blood Pressure Screening Results From China</title><source>PubMed (Medline)</source><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Wiley Open Access</source><creator>Chen, Xin ; Zhang, Li-Ping ; Wang, Xiao-Long ; Zhang, Ning-Ru ; Yu, Jing ; Xu, Li-Ying ; Li, Tong-She ; Luan, Hong ; Zhang, Juan ; Hu, Ya-Min ; Liu, Dan ; Zheng, Qi-Dong ; Li, Yan ; Wang, Ji-Guang</creator><creatorcontrib>Chen, Xin ; Zhang, Li-Ping ; Wang, Xiao-Long ; Zhang, Ning-Ru ; Yu, Jing ; Xu, Li-Ying ; Li, Tong-She ; Luan, Hong ; Zhang, Juan ; Hu, Ya-Min ; Liu, Dan ; Zheng, Qi-Dong ; Li, Yan ; Wang, Ji-Guang</creatorcontrib><description>We reported the blood pressure data obtained in the May Measurement Month (MMM) China project in 2020 during the COVID-19 control period. The study participants were adults (≥ 18 years), ideally in whom blood pressure had not been measured in the previous year. Blood pressure was measured three times consecutively with a 1-min interval in the sitting position, using a validated automated BP monitor (Omron HEM-7081IT), and transmitted to a central database via a smartphone app. The measurement was performed at 136 sites across 29 China provinces. The 100 728 participants had a mean (±SD) age of 45.6 (±18.3) years and included 56 097 (55.7%) women. The mean systolic/diastolic blood pressure was 120.0/76.9 mm Hg. The proportion of hypertension was 28.9% (n = 29 135), and the awareness, treatment, and control rates of hypertension were 45.3% (n = 13 212), 39.7% (n = 1573), and 24.4% (n = 7101), respectively. After adjustment for age, gender, and use of antihypertensive medication, systolic/diastolic BP were significantly higher with cigarette smoking (n = 8070, +0.5/+1.0 mm Hg, p < 0.05), mild (n = 4369, +1.2/+1.3 mm Hg, p < 0.001) and moderate or heavy alcohol drinking (n = 3871, +0.4/+0.7 mm Hg, p < 0.05), and overweight (+1.8/+1.4 mm Hg, p < 0.001) and obesity (+2.3/+1.5 mm Hg, p < 0.001). In conclusion, our study provided unique blood pressure data during the COVID-19 period, and suggested that hypertension management might have been even more challenging when the medical professionals had to shift their focus on other urgencies.</description><identifier>ISSN: 1524-6175</identifier><identifier>ISSN: 1751-7176</identifier><identifier>EISSN: 1751-7176</identifier><identifier>DOI: 10.1111/jch.14919</identifier><identifier>PMID: 39437795</identifier><language>eng</language><publisher>United States: John Wiley and Sons Inc</publisher><subject>Adult ; Aged ; Blood Pressure - physiology ; Blood Pressure Determination - methods ; Blood Pressure Determination - statistics & numerical data ; China - epidemiology ; COVID-19 - epidemiology ; Female ; Humans ; Hypertension - diagnosis ; Hypertension - drug therapy ; Hypertension - epidemiology ; Hypertension - physiopathology ; Male ; Mass Screening - methods ; Middle Aged ; SARS-CoV-2 ; Short</subject><ispartof>The journal of clinical hypertension (Greenwich, Conn.), 2025-01, Vol.27 (1), p.1-4</ispartof><rights>2025 The Author(s). The Journal of Clinical Hypertension published by Wiley Periodicals LLC.</rights><rights>2025 The Author(s). published by Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c231t-8263d50d896d171a541e1da17baf42dde47e8dc3c6fe264f2122edf3eb7369913</cites><orcidid>0000-0002-5825-5968 ; 0000-0002-7970-6991</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11729741/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11729741/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,36992,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39437795$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Xin</creatorcontrib><creatorcontrib>Zhang, Li-Ping</creatorcontrib><creatorcontrib>Wang, Xiao-Long</creatorcontrib><creatorcontrib>Zhang, Ning-Ru</creatorcontrib><creatorcontrib>Yu, Jing</creatorcontrib><creatorcontrib>Xu, Li-Ying</creatorcontrib><creatorcontrib>Li, Tong-She</creatorcontrib><creatorcontrib>Luan, Hong</creatorcontrib><creatorcontrib>Zhang, Juan</creatorcontrib><creatorcontrib>Hu, Ya-Min</creatorcontrib><creatorcontrib>Liu, Dan</creatorcontrib><creatorcontrib>Zheng, Qi-Dong</creatorcontrib><creatorcontrib>Li, Yan</creatorcontrib><creatorcontrib>Wang, Ji-Guang</creatorcontrib><title>May Measurement Month 2020: An Analysis of Blood Pressure Screening Results From China</title><title>The journal of clinical hypertension (Greenwich, Conn.)</title><addtitle>J Clin Hypertens (Greenwich)</addtitle><description>We reported the blood pressure data obtained in the May Measurement Month (MMM) China project in 2020 during the COVID-19 control period. The study participants were adults (≥ 18 years), ideally in whom blood pressure had not been measured in the previous year. Blood pressure was measured three times consecutively with a 1-min interval in the sitting position, using a validated automated BP monitor (Omron HEM-7081IT), and transmitted to a central database via a smartphone app. The measurement was performed at 136 sites across 29 China provinces. The 100 728 participants had a mean (±SD) age of 45.6 (±18.3) years and included 56 097 (55.7%) women. The mean systolic/diastolic blood pressure was 120.0/76.9 mm Hg. The proportion of hypertension was 28.9% (n = 29 135), and the awareness, treatment, and control rates of hypertension were 45.3% (n = 13 212), 39.7% (n = 1573), and 24.4% (n = 7101), respectively. After adjustment for age, gender, and use of antihypertensive medication, systolic/diastolic BP were significantly higher with cigarette smoking (n = 8070, +0.5/+1.0 mm Hg, p < 0.05), mild (n = 4369, +1.2/+1.3 mm Hg, p < 0.001) and moderate or heavy alcohol drinking (n = 3871, +0.4/+0.7 mm Hg, p < 0.05), and overweight (+1.8/+1.4 mm Hg, p < 0.001) and obesity (+2.3/+1.5 mm Hg, p < 0.001). In conclusion, our study provided unique blood pressure data during the COVID-19 period, and suggested that hypertension management might have been even more challenging when the medical professionals had to shift their focus on other urgencies.</description><subject>Adult</subject><subject>Aged</subject><subject>Blood Pressure - physiology</subject><subject>Blood Pressure Determination - methods</subject><subject>Blood Pressure Determination - statistics & numerical data</subject><subject>China - epidemiology</subject><subject>COVID-19 - epidemiology</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension - diagnosis</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - epidemiology</subject><subject>Hypertension - physiopathology</subject><subject>Male</subject><subject>Mass Screening - methods</subject><subject>Middle Aged</subject><subject>SARS-CoV-2</subject><subject>Short</subject><issn>1524-6175</issn><issn>1751-7176</issn><issn>1751-7176</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><recordid>eNpVkdtKxDAQhoMoni98AcmlXlQ7Sdo03si6eAIXxdNtyDbTbaVt1qQV9u3telg0DCTMfPyZmZ-QA4hPYDinb3l5AkKBWiPbIBOIJMh0fXgnTETpkNkiOyG8xXHCuYo3yRZXgkupkm3yOjELOkETeo8Nth2duLYrKYtZfEZH7RCmXoQqUFfQi9o5Sx88hiVNn3KP2FbtjD5i6Osu0CvvGjouq9bskY3C1AH3f-5d8nJ1-Ty-ie7ur2_Ho7soZxy6KGMpt0lsM5VakGASAQjWgJyaQjBrUUjMbM7ztECWioIBY2gLjlPJU6WA75Lzb915P23Q5sME3tR67qvG-IV2ptL_K21V6pn70ACSKSmWCkc_Ct699xg63VQhx7o2Lbo-aA6gJOOCZQN6_I3m3oXgsVj9A7FeGqEHI_SXEQN7-LexFfm7ef4Je1SDgA</recordid><startdate>202501</startdate><enddate>202501</enddate><creator>Chen, Xin</creator><creator>Zhang, Li-Ping</creator><creator>Wang, Xiao-Long</creator><creator>Zhang, Ning-Ru</creator><creator>Yu, Jing</creator><creator>Xu, Li-Ying</creator><creator>Li, Tong-She</creator><creator>Luan, Hong</creator><creator>Zhang, Juan</creator><creator>Hu, Ya-Min</creator><creator>Liu, Dan</creator><creator>Zheng, Qi-Dong</creator><creator>Li, Yan</creator><creator>Wang, Ji-Guang</creator><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5825-5968</orcidid><orcidid>https://orcid.org/0000-0002-7970-6991</orcidid></search><sort><creationdate>202501</creationdate><title>May Measurement Month 2020: An Analysis of Blood Pressure Screening Results From China</title><author>Chen, Xin ; Zhang, Li-Ping ; Wang, Xiao-Long ; Zhang, Ning-Ru ; Yu, Jing ; Xu, Li-Ying ; Li, Tong-She ; Luan, Hong ; Zhang, Juan ; Hu, Ya-Min ; Liu, Dan ; Zheng, Qi-Dong ; Li, Yan ; Wang, Ji-Guang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c231t-8263d50d896d171a541e1da17baf42dde47e8dc3c6fe264f2122edf3eb7369913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Blood Pressure - physiology</topic><topic>Blood Pressure Determination - methods</topic><topic>Blood Pressure Determination - statistics & numerical data</topic><topic>China - epidemiology</topic><topic>COVID-19 - epidemiology</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension - diagnosis</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - epidemiology</topic><topic>Hypertension - physiopathology</topic><topic>Male</topic><topic>Mass Screening - methods</topic><topic>Middle Aged</topic><topic>SARS-CoV-2</topic><topic>Short</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Xin</creatorcontrib><creatorcontrib>Zhang, Li-Ping</creatorcontrib><creatorcontrib>Wang, Xiao-Long</creatorcontrib><creatorcontrib>Zhang, Ning-Ru</creatorcontrib><creatorcontrib>Yu, Jing</creatorcontrib><creatorcontrib>Xu, Li-Ying</creatorcontrib><creatorcontrib>Li, Tong-She</creatorcontrib><creatorcontrib>Luan, Hong</creatorcontrib><creatorcontrib>Zhang, Juan</creatorcontrib><creatorcontrib>Hu, Ya-Min</creatorcontrib><creatorcontrib>Liu, Dan</creatorcontrib><creatorcontrib>Zheng, Qi-Dong</creatorcontrib><creatorcontrib>Li, Yan</creatorcontrib><creatorcontrib>Wang, Ji-Guang</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The journal of clinical hypertension (Greenwich, Conn.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Xin</au><au>Zhang, Li-Ping</au><au>Wang, Xiao-Long</au><au>Zhang, Ning-Ru</au><au>Yu, Jing</au><au>Xu, Li-Ying</au><au>Li, Tong-She</au><au>Luan, Hong</au><au>Zhang, Juan</au><au>Hu, Ya-Min</au><au>Liu, Dan</au><au>Zheng, Qi-Dong</au><au>Li, Yan</au><au>Wang, Ji-Guang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>May Measurement Month 2020: An Analysis of Blood Pressure Screening Results From China</atitle><jtitle>The journal of clinical hypertension (Greenwich, Conn.)</jtitle><addtitle>J Clin Hypertens (Greenwich)</addtitle><date>2025-01</date><risdate>2025</risdate><volume>27</volume><issue>1</issue><spage>1</spage><epage>4</epage><pages>1-4</pages><issn>1524-6175</issn><issn>1751-7176</issn><eissn>1751-7176</eissn><abstract>We reported the blood pressure data obtained in the May Measurement Month (MMM) China project in 2020 during the COVID-19 control period. The study participants were adults (≥ 18 years), ideally in whom blood pressure had not been measured in the previous year. Blood pressure was measured three times consecutively with a 1-min interval in the sitting position, using a validated automated BP monitor (Omron HEM-7081IT), and transmitted to a central database via a smartphone app. The measurement was performed at 136 sites across 29 China provinces. The 100 728 participants had a mean (±SD) age of 45.6 (±18.3) years and included 56 097 (55.7%) women. The mean systolic/diastolic blood pressure was 120.0/76.9 mm Hg. The proportion of hypertension was 28.9% (n = 29 135), and the awareness, treatment, and control rates of hypertension were 45.3% (n = 13 212), 39.7% (n = 1573), and 24.4% (n = 7101), respectively. After adjustment for age, gender, and use of antihypertensive medication, systolic/diastolic BP were significantly higher with cigarette smoking (n = 8070, +0.5/+1.0 mm Hg, p < 0.05), mild (n = 4369, +1.2/+1.3 mm Hg, p < 0.001) and moderate or heavy alcohol drinking (n = 3871, +0.4/+0.7 mm Hg, p < 0.05), and overweight (+1.8/+1.4 mm Hg, p < 0.001) and obesity (+2.3/+1.5 mm Hg, p < 0.001). In conclusion, our study provided unique blood pressure data during the COVID-19 period, and suggested that hypertension management might have been even more challenging when the medical professionals had to shift their focus on other urgencies.</abstract><cop>United States</cop><pub>John Wiley and Sons Inc</pub><pmid>39437795</pmid><doi>10.1111/jch.14919</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-5825-5968</orcidid><orcidid>https://orcid.org/0000-0002-7970-6991</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1524-6175 |
ispartof | The journal of clinical hypertension (Greenwich, Conn.), 2025-01, Vol.27 (1), p.1-4 |
issn | 1524-6175 1751-7176 1751-7176 |
language | eng |
recordid | cdi_proquest_miscellaneous_3119723428 |
source | PubMed (Medline); Publicly Available Content Database (Proquest) (PQ_SDU_P3); Wiley Open Access |
subjects | Adult Aged Blood Pressure - physiology Blood Pressure Determination - methods Blood Pressure Determination - statistics & numerical data China - epidemiology COVID-19 - epidemiology Female Humans Hypertension - diagnosis Hypertension - drug therapy Hypertension - epidemiology Hypertension - physiopathology Male Mass Screening - methods Middle Aged SARS-CoV-2 Short |
title | May Measurement Month 2020: An Analysis of Blood Pressure Screening Results From China |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T11%3A55%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=May%20Measurement%20Month%202020:%20An%20Analysis%20of%20Blood%20Pressure%20Screening%20Results%20From%20China&rft.jtitle=The%20journal%20of%20clinical%20hypertension%20(Greenwich,%20Conn.)&rft.au=Chen,%20Xin&rft.date=2025-01&rft.volume=27&rft.issue=1&rft.spage=1&rft.epage=4&rft.pages=1-4&rft.issn=1524-6175&rft.eissn=1751-7176&rft_id=info:doi/10.1111/jch.14919&rft_dat=%3Cproquest_pubme%3E3119723428%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c231t-8263d50d896d171a541e1da17baf42dde47e8dc3c6fe264f2122edf3eb7369913%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3119723428&rft_id=info:pmid/39437795&rfr_iscdi=true |